OL
Insider
OrbiMed Genesis GP LLC
DirectorOrbiMed Genesis GP LLC (Director) filed 2 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 0 sales), most often in Edgewise Therapeutics, Inc. (EWTX). Across 2 priced purchase filings, the average 21-session return was +5.7% from execution and +4.1% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of EWTX (496,771 sh across 2 lots, as filed), executed Apr 3 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+5.7%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+4.1%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.0M
shares × price, as filed
Last traded
Apr 3 2025
Filed Apr 4 2025
Median ADV $64.2M across their filed names
Open performance→Volume by month
Buys $12.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
EWTXRecent filings
EWTXPURCHASE
Edgewise Therapeutics, Inc.
View filing →
$10.0M496,771 sh across 2 lots
Exec Apr 3 2025
Filed Apr 4 2025 · 5:30 PM ET MBXPURCHASE MBX Biosciences, Inc. View filing → $2.0M
190,672 sh across 4 lots
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET